A recent analysis of a massive study observing the effect of food on the health of nearly 200,000 American health professionals suggested eating more gluten was associated with a lower risk of type 2 diabetes. Read more
Liraglutide 3·0 mg was shown to reduce bodyweight and improve glucose metabolism after the 56-week period of this trial, one of four trials in the SCALE programme. Read more
Researchers in Sweden are planning the clinical trial of a new treatment for nonalcoholic fatty liver disease and type 2 diabetes which harnesses liver cells' own ability to burn accumulated fats. Read more
Slowing Down the Progression of Type 2 Diabetes: We Need Fair, Innovative, and Disruptive Action on Environmental and Policy Levels!
Over the past decades, we have observed an increase of prevalence of diabetes in many countries along with significant differences in prevalence trends between countries worldwide (1). In Europe and other Western countries, the prevalence rate reaches a plateau or has slowed down on the level of ∼8–10%. In Asia, a continuous rise in prevalence [...]
Every day an estimated 280 Australians develop type 2 diabetes.1 By 2023, type 2 diabetes is predicted to become the number one specific cause of burden of disease in Australia.2 Policies and programs to support the prevention of type 2 diabetes need to be scaled up urgently if Australia hopes to limit or reduce the [...]